Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.

Eisinger RW, Dieffenbach CW, Fauci AS.

JAMA. 2019 Feb 5;321(5):451-452. doi: 10.1001/jama.2018.21167. No abstract available.

PMID:
30629090
2.

Ending the HIV Epidemic in the United States: Closing the Implementation Gaps.

Marston HD, Dieffenbach CW, Fauci AS.

Ann Intern Med. 2018 Sep 18;169(6):411-412. doi: 10.7326/M18-1944. Epub 2018 Aug 21. No abstract available.

PMID:
30140920
3.

Polymyositis as a presentation of advanced carcinoma of Mullerian origin: A case report and discussion.

Dieffenbach C, Bouberhan S, Raynor E, Shea M, Liu F.

Gynecol Oncol Rep. 2018 May 1;25:1-2. doi: 10.1016/j.gore.2018.04.010. eCollection 2018 Aug.

4.

Immunology. Immune activation with HIV vaccines.

Fauci AS, Marovich MA, Dieffenbach CW, Hunter E, Buchbinder SP.

Science. 2014 Apr 4;344(6179):49-51. doi: 10.1126/science.1250672. No abstract available.

5.

HIV-AIDS: much accomplished, much to do.

Fauci AS, Folkers GK, Dieffenbach CW.

Nat Immunol. 2013 Nov;14(11):1104-7. doi: 10.1038/ni.2735.

PMID:
24145780
6.

Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.

Dieffenbach CW.

Curr Opin HIV AIDS. 2012 Mar;7(2):106-10. doi: 10.1097/COH.0b013e32834f3f13. Review.

PMID:
22227584
7.

Thirty years of HIV and AIDS: future challenges and opportunities.

Dieffenbach CW, Fauci AS.

Ann Intern Med. 2011 Jun 7;154(11):766-71. doi: 10.7326/0003-4819-154-11-201106070-00345. Epub 2011 May 31.

PMID:
21628350
8.

HIV-1 vaccines and adaptive trial designs.

Corey L, Nabel GJ, Dieffenbach C, Gilbert P, Haynes BF, Johnston M, Kublin J, Lane HC, Pantaleo G, Picker LJ, Fauci AS.

Sci Transl Med. 2011 Apr 20;3(79):79ps13. doi: 10.1126/scitranslmed.3001863.

9.

A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States.

Millett GA, Crowley JS, Koh H, Valdiserri RO, Frieden T, Dieffenbach CW, Fenton KA, Benjamin R, Whitescarver J, Mermin J, Parham-Hopson D, Fauci AS.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S144-7. doi: 10.1097/QAI.0b013e3181fbcb04.

PMID:
21406986
10.

Towards a more coordinated federal response to improving HIV prevention and sexual health among men who have sex with men.

Rausch D, Dieffenbach C, Cheever L, Fenton KA.

AIDS Behav. 2011 Apr;15 Suppl 1:S107-11. doi: 10.1007/s10461-011-9908-z. No abstract available.

PMID:
21365306
11.

Rethinking prevention of HIV type 1 infection.

Burns DN, Dieffenbach CW, Vermund SH.

Clin Infect Dis. 2010 Sep 15;51(6):725-31. doi: 10.1086/655889. Review. Erratum in: Clin Infect Dis. 2010 Oct 15;51(8):995.

12.

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

Kim SC, Becker S, Dieffenbach C, Hanewall BS, Hankins C, Lo YR, Mellors JW, O'Reilly K, Paxton L, Roffenbender JS, Warren M, Piot P, Dybul MR.

J Int AIDS Soc. 2010 Jul 12;13:24. doi: 10.1186/1758-2652-13-24.

13.

Fighting HIV/AIDS in Washington, D.C.

Greenberg AE, Hader SL, Masur H, Young AT, Skillicorn J, Dieffenbach CW.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1677-87. doi: 10.1377/hlthaff.28.6.1677.

PMID:
19887408
14.

HIV vaccine development: Lessons from the past, informing the future.

Bradac J, Dieffenbach CW.

IDrugs. 2009 Jul;12(7):435-9. Review.

PMID:
19579164
15.

Universal voluntary testing and treatment for prevention of HIV transmission.

Dieffenbach CW, Fauci AS.

JAMA. 2009 Jun 10;301(22):2380-2. doi: 10.1001/jama.2009.828. No abstract available.

PMID:
19509386
16.

Cataloguing the HIV type 1 human protein interaction network.

Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, Robertson DL, Rozanov MN, Katz KS, Maglott DR, Pruitt KD, Dieffenbach CW.

AIDS Res Hum Retroviruses. 2008 Dec;24(12):1497-502. doi: 10.1089/aid.2008.0113. Review.

17.

HIV vaccine research: the way forward.

Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC.

Science. 2008 Jul 25;321(5888):530-2. doi: 10.1126/science.1161000.

PMID:
18653883
18.

Defining and solving the essential protein-protein interactions in HIV infection.

Finzi D, Dieffenbach CW, Basavappa R.

J Struct Biol. 2007 May;158(2):148-55. Epub 2006 Nov 9. Review.

PMID:
17175170
19.

Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Finzi D, Plaeger SF, Dieffenbach CW.

Clin Vaccine Immunol. 2006 Jul;13(7):715-21. Review. No abstract available.

20.

General concepts for PCR primer design.

Dieffenbach CW, Lowe TM, Dveksler GS.

PCR Methods Appl. 1993 Dec;3(3):S30-7. No abstract available.

21.

Induction of IFN-gamma in macrophages by lipopolysaccharide.

Fultz MJ, Barber SA, Dieffenbach CW, Vogel SN.

Int Immunol. 1993 Nov;5(11):1383-92.

PMID:
8260452
22.

Setting up a PCR laboratory.

Dieffenbach CW, Dveksler GS.

PCR Methods Appl. 1993 Oct;3(2):S2-7. No abstract available.

23.
24.

Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor.

Dveksler GS, Pensiero MN, Dieffenbach CW, Cardellichio CB, Basile AA, Elia PE, Holmes KV.

Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1716-20.

25.

Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.

Dveksler GS, Dieffenbach CW, Cardellichio CB, McCuaig K, Pensiero MN, Jiang GS, Beauchemin N, Holmes KV.

J Virol. 1993 Jan;67(1):1-8.

26.

Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice.

Dveksler GS, Basile AA, Cardellichio CB, Beauchemin N, Dieffenbach CW, Holmes KV.

Adv Exp Med Biol. 1993;342:267-72. No abstract available.

PMID:
8209741
27.

Coronavirus receptor specificity.

Holmes KV, Dveksler G, Gagneten S, Yeager C, Lin SH, Beauchemin N, Look AT, Ashmun R, Dieffenbach C.

Adv Exp Med Biol. 1993;342:261-6. Review. No abstract available.

PMID:
8209740
28.

Hantaan virus infection of human endothelial cells.

Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J.

J Virol. 1992 Oct;66(10):5929-36.

29.
30.

Cloning and expression of human erythropoietin, a paradigm.

Dieffenbach CW.

J Vasc Surg. 1992 May;15(5):909-11. No abstract available.

PMID:
1578562
31.

Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase.

Dveksler GS, Basile AA, Dieffenbach CW.

PCR Methods Appl. 1992 May;1(4):283-5. No abstract available.

32.

Effect of different laboratory techniques for guanidinium-phenol-chloroform RNA extraction on A260/A280 and on accuracy of mRNA quantitation by reverse transcriptase-PCR.

Yamaguchi M, Dieffenbach CW, Connolly R, Cruess DF, Baur W, Sharefkin JB.

PCR Methods Appl. 1992 May;1(4):286-90. No abstract available.

33.

Spontaneous expression of interferon genes in murine peritoneal macrophages: modulation during the in vitro aging.

Conti L, Di Marzio P, Gessani S, Borghi P, Varano B, Dieffenbach C, Belardelli F.

Arch Gerontol Geriatr. 1992;15 Suppl 1:123-8.

PMID:
18647682
34.

Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.

Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, Dieffenbach CW.

J Virol. 1991 Dec;65(12):6881-91.

35.

Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures.

Szebeni J, Dieffenbach C, Wahl SM, Venkateshan CN, Yeh A, Popovic M, Gartner S, Wahl LM, Peterfy M, Friedman RM, et al.

J Virol. 1991 Nov;65(11):6362-4.

36.

Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Svetić A, Finkelman FD, Jian YC, Dieffenbach CW, Scott DE, McCarthy KF, Steinberg AD, Gause WC.

J Immunol. 1991 Oct 1;147(7):2391-7.

PMID:
1717559
37.
38.

Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells.

Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW.

J Vasc Surg. 1991 Jul;14(1):1-9.

PMID:
2061949
39.

Detection of toxic viral-associated double-stranded RNA (dsRNA) in influenza-infected lung.

Majde JA, Brown RK, Jones MW, Dieffenbach CW, Maitra N, Krueger JM, Cady AB, Smitka CW, Maassab HF.

Microb Pathog. 1991 Feb;10(2):105-15.

PMID:
1890949
40.

A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.

Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, Dieffenbach C.

J Exp Med. 1991 Jan 1;173(1):277. No abstract available.

41.

Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus.

Meltzer MS, Baca L, Turpin JA, Kalter DC, Dieffenbach C, Friedman RM, Gendelman HE.

Pathobiology. 1991;59(4):209-13. Review.

PMID:
1883515
42.

Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes.

Kalter DC, Nakamura M, Turpin JA, Baca LM, Hoover DL, Dieffenbach C, Ralph P, Gendelman HE, Meltzer MS.

J Immunol. 1991 Jan 1;146(1):298-306.

PMID:
1701795
43.

Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.

Locardi C, Petrini C, Boccoli G, Testa U, Dieffenbach C, Buttò S, Belardelli F.

J Virol. 1990 Dec;64(12):5874-82. Erratum in: J Virol 1991 Mar;65(3):1666.

44.

A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.

Gendelman HE, Friedman RM, Joe S, Baca LM, Turpin JA, Dveksler G, Meltzer MS, Dieffenbach C.

J Exp Med. 1990 Nov 1;172(5):1433-42. Erratum in: J Exp Med. 1991 Jan 1;173(1):277.

45.

2',5'-Oligoadenylate synthetase gene expression in revertants of ras-transformed NIH3T3 fibroblasts.

Rimoldi D, Dieffenbach CW, Friedman RM, Samid D.

Exp Cell Res. 1990 Nov;191(1):76-82.

PMID:
1699771
46.

Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.

Gendelman HE, Baca LM, Turpin J, Kalter DC, Hansen B, Orenstein JM, Dieffenbach CW, Friedman RM, Meltzer MS.

J Immunol. 1990 Oct 15;145(8):2669-76.

PMID:
1976701
47.

Induction of interferon-beta and 2',5'-oligoadenylate synthetase mRNAs by interleukin 6 during differentiation of murine myeloid cells.

Bickel M, Dveksler G, Dieffenbach CW, Ruhl S, Midura SB, Pluznik DH.

Cytokine. 1990 Jul;2(4):238-46. Erratum in: Cytokine. 1990 Nov;2(6):473.

PMID:
2151766
48.

Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress.

Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, McIntire LV, Eskin SG.

J Cell Physiol. 1990 May;143(2):364-71.

PMID:
2110169
49.

A computer program for selection of oligonucleotide primers for polymerase chain reactions.

Lowe T, Sharefkin J, Yang SQ, Dieffenbach CW.

Nucleic Acids Res. 1990 Apr 11;18(7):1757-61.

50.

Interactions between interferon and the human immunodeficiency virus.

Gendelman HE, Baca LM, Turpin JA, Kalter DC, Dieffenbach C, Friedman RM, Meltzer MS.

J Exp Pathol. 1990;5(2):53-67. No abstract available.

PMID:
1708817

Supplemental Content

Loading ...
Support Center